AWARENESS, ATTITUDES, AND PRACTICES RELATED TO WEIGHT-LOSS DRUGS AND GYM SUPPLEMENTS AMONG YOUNG ADULTS: A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
...
Abstract
Background: Use of weight-loss drugs, anabolic steroids, and gym supplements has increased substantially among young adults, driven by body-image perceptions, social-media exposure, and unregulated markets. Several studies document serious adverse effects associated with unsupervised consumption (1–4).
Objectives: To assess awareness, attitudes, and practices regarding weight-loss drugs and gym supplements among young adults aged 18–35 years.
Methods: A cross-sectional study was conducted among 250 participants using a validated online questionnaire consisting of demographic, behavioural, knowledge, attitude, and practice domains. Knowledge scoring followed a predefined answer key. Data were analysed using descriptive statistics, chi-square tests, and logistic regression.
Results: Mean age was 21.8 ± 2.3 years; 56.4% were female. A total of 38.8% reported currently attempting weight loss. Supplement use was reported by 41.2%, with gym trainers and social-media influencers being major sources of recommendations. Only 28.4% achieved high knowledge scores. Unsupervised supplement use was significantly associated with overweight/obesity (p = 0.018). Independent predictors of unsafe supplement use included gym-trainer influence and poor knowledge levels.
Conclusion: Knowledge gaps and unsafe practices remain widespread among young adults. Non-medical influencers play a dominant role in decision-making. Structured educational interventions and regulatory monitoring are urgently needed.
References
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity. Lancet.2014;384:766–781.
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide for weight management. N Engl J Med.2021;384:989–1002.
4. Garthe I, Maughan RJ. Athletes and dietary supplements: prevalence and risks. Sports Med. 2018;48:1–16.
5. Goston JL, Correia MIT. Intake of nutritional supplements among people exercising in gyms. Nutrition.2010;26(6):604–611.
6. Hildebrandt T, Harty S, Langenbucher JW. Fitness supplements and appearance-driven use in young adults. Eat Behav. 2012;13:89–92.
7. Padwal R, Majumdar SR. Orlistat: a review of the anti-obesity drug. CMAJ. 2007;176(8):1063–1070.
8. Nauck MA, Meier JJ. Safety of GLP-1 receptor agonists. Diabetes Obes Metab. 2019;21 Suppl 1:37–45.
9. Coward RM, Rajanahally S, Kovac JR, et al. Anabolic steroid exposure and male infertility. Fertil Steril.2013;99(3):964–971.
10. Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse. Lancet Psychiatry. 2015;2: 382–392.
11. de Ronde W, Smit DL. Anabolic–androgenic steroid abuse in young males. Nat Rev Endocrinol. 2020;16:421–432.
12. Pomeranz JL, Taylor L. Caffeine-containing pre-workout supplements and adverse cardiac events. JAMA Intern Med. 2019;179:1–2.
13. Cohen PA, Venhuis BJ, Masten SA. Adulterated dietary supplements in the United States. Drug Test Anal.2021;13(4–5):415–425.
14. Morrison LJ, Gizis F, Shorter B. Nutritional supplement use in college athletes. J Am Diet Assoc. 2004;104(3): 472–474.
15. Erdman KA, Fung TS, Reimer RA. Dietary supplementation knowledge among medical students. Appl Physiol Nutr Metab. 2006;31(2):167–174.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr.Navneeth Selvan
Department of Pharmacology, Indira Medical College and Hospitals, Thiruvallur
